Quarterly Results We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need. IR Sub Menu Financials & Filings SEC Filings Quarterly Results Show all 2021 Q1 Poseida Therapeutics Reports Program Updates and Financial Results for the First Quarter 2021 Form 10-Q 2020 Q4 Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 Form 10-K Q3 Poseida Therapeutics Reports Operational Update and Financial Results for Third Quarter 2020 Form 10-Q Q2 Poseida Therapeutics Reports Operational Update and Financial Results for Second Quarter and First Half of 2020 Form 10-Q
Show all 2021 Q1 Poseida Therapeutics Reports Program Updates and Financial Results for the First Quarter 2021 Form 10-Q 2020 Q4 Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 Form 10-K Q3 Poseida Therapeutics Reports Operational Update and Financial Results for Third Quarter 2020 Form 10-Q Q2 Poseida Therapeutics Reports Operational Update and Financial Results for Second Quarter and First Half of 2020 Form 10-Q